Yumanity Therapeutics (FRA:8IY) Interest Expense : €-0.88 Mil (TTM As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Yumanity Therapeutics's interest expense for the three months ended in Sep. 2022 was € -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2022 was €-0.88 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Yumanity Therapeutics's Operating Income for the three months ended in Sep. 2022 was € -3.54 Mil. Yumanity Therapeutics's Interest Expense for the three months ended in Sep. 2022 was € -0.00 Mil. Yumanity Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Yumanity Therapeutics Interest Expense Historical Data

The historical data trend for Yumanity Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Interest Expense Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Interest Expense

-1.09

-1.59

-1.67

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Interest Expense	Get a 7-Day Free Trial							-0.39	-0.35	-0.53	-0.01	-

Yumanity Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.88 Mil.

Yumanity Therapeutics (FRA:8IY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Yumanity Therapeutics's Interest Expense for the three months ended in Sep. 2022 was €-0.00 Mil. Its Operating Income for the three months ended in Sep. 2022 was €-3.54 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2022 was €0.00 Mil.

Yumanity Therapeutics's Interest Coverage for the quarter that ended in Sep. 2022 is calculated as

Yumanity Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines